Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential information.
The decision came to light following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson later explained that the United States was seeking health data for research and commercial gain while refused to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more talks to secure a agreement acceptable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Background
This rejection follows a similar situation in Kenya, where a court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our nation would provide the raw materials for medical research without any certainty that the resulting innovations would be available to our population should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting systems previously set up via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This framework is designed to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome further dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body expressed it understood the government's concerns, but suggested that negotiations should continue given that much of the nation's Aids initiatives were funded by foreign aid.
"If technical issues exist, such as those relating to information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.
The situation highlights the ongoing challenges between receiving much-needed international aid and safeguarding local interests in an ever more data-driven world.